{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:16:37Z","timestamp":1761293797655},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00104-018-0718-y","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T07:13:40Z","timestamp":1536045220000},"page":"858-864","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Aktueller Therapiealgorithmus des intrahepatischen cholangiozellul\u00e4ren Karzinoms"],"prefix":"10.1007","volume":"89","author":[{"given":"G.","family":"Lurje","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bednarsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Roderburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U. P.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"issue":"8","key":"718_CR1","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/ajg.2012.173","volume":"107","author":"JD Yang","year":"2012","unstructured":"Yang JD, Kim B, Sanderson SO, Sauver JS, Yawn BP, Larson JJ et\u00a0al (2012) Biliary tract cancers in Olmsted County, Minnesota, 1976\u20132008. Am J Gastroenterol 107(8):1256\u20131262","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"718_CR2","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3109\/00365521.2011.589472","volume":"46","author":"T Hahn von","year":"2011","unstructured":"von Hahn T, Ciesek S, Wegener G, Plentz RR, Weismuller TJ, Wedemeyer H et\u00a0al (2011) Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany. Scand J Gastroenterol 46(9):1092\u20131098","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"718_CR3","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","volume":"145","author":"S Rizvi","year":"2013","unstructured":"Rizvi S, Gores GJ (2013) Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 145(6):1215\u20131229","journal-title":"Gastroenterology"},{"issue":"2","key":"718_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s002920000416","volume":"22","author":"A Tannapfel","year":"2001","unstructured":"Tannapfel A, Wittekind C (2001) Anatomie und Pathologie des intrahepatischen und extrahepatischen Gallengangskarzinoms. Pathologe 22(2):114\u2013123","journal-title":"Pathologe"},{"issue":"6","key":"718_CR5","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0168-8278(02)00297-0","volume":"37","author":"SA Khan","year":"2002","unstructured":"Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J\u00a0Hepatol 37(6):806\u2013813","journal-title":"J Hepatol"},{"issue":"1","key":"718_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","volume":"57","author":"WC Palmer","year":"2012","unstructured":"Palmer WC, Patel T (2012) Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J\u00a0Hepatol 57(1):69\u201376","journal-title":"J Hepatol"},{"issue":"4","key":"718_CR7","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jamcollsurg.2013.05.021","volume":"217","author":"RM Dodson","year":"2013","unstructured":"Dodson RM, Weiss MJ, Cosgrove D, Herman JM, Kamel I, Anders R et\u00a0al (2013) Intrahepatic cholangiocarcinoma: management options and emerging therapies. J\u00a0Am Coll Surg 217(4):736\u2013750.e4","journal-title":"J Am Coll Surg"},{"issue":"8","key":"718_CR8","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.crad.2012.01.004","volume":"67","author":"YS Chong","year":"2012","unstructured":"Chong YS, Kim YK, Lee MW, Kim SH, Lee WJ, Rhim HC et al (2012) Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI. Clin Radiol 67(8):766\u2013773","journal-title":"Clin Radiol"},{"issue":"1","key":"718_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jhep.2006.03.009","volume":"45","author":"H Petrowsky","year":"2006","unstructured":"Petrowsky H, Wildbrett P, Husarik DB, Hany TF, Tam S, Jochum W et\u00a0al (2006) Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J\u00a0Hepatol 45(1):43\u201350","journal-title":"J Hepatol"},{"issue":"2","key":"718_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/13651820801992583","volume":"10","author":"S Breitenstein","year":"2008","unstructured":"Breitenstein S, Apestegui C, Clavien PA (2008) Positron emission tomography (PET) for cholangiocarcinoma. HPB (Oxford) 10(2):120\u2013121","journal-title":"HPB (Oxford)"},{"issue":"1","key":"718_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jamcollsurg.2007.07.002","volume":"206","author":"CU Corvera","year":"2008","unstructured":"Corvera CU, Blumgart LH, Akhurst T, DeMatteo RP, D\u2019Angelica M, Fong Y et al (2008) 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J\u00a0Am Coll Surg 206(1):57\u201365","journal-title":"J Am Coll Surg"},{"issue":"2","key":"718_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.bpg.2015.02.007","volume":"29","author":"UP Neumann","year":"2015","unstructured":"Neumann UP, Schmeding M (2015) Role of surgery in cholangiocarcinoma: from resection to transplantation. Best Pract Res Clin Gastroenterol 29(2):295\u2013308","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5","key":"718_CR13","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/SLA.0000000000001450","volume":"262","author":"E Schadde","year":"2015","unstructured":"Schadde E, Raptis DA, Schnitzbauer AA, Ardiles V, Tschuor C, Lesurtel M et al (2015) Prediction of mortality after ALPPS stage-1: an analysis of 320 patients from the international ALPPS registry. Ann Surg 262(5):780\u2013785 (discussion 5\u20136)","journal-title":"Ann Surg"},{"issue":"11","key":"718_CR14","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1001\/archsurg.138.11.1198","volume":"138","author":"H Imamura","year":"2003","unstructured":"Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K et al (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138(11):1198\u20131206 (discussion 206)","journal-title":"Arch Surg"},{"issue":"2","key":"718_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1478-3231.2004.00901.x","volume":"24","author":"D Erdogan","year":"2004","unstructured":"Erdogan D, Heijnen BH, Bennink RJ, Kok M, Dinant S, Straatsburg IH et al (2004) Preoperative assessment of liver function: a\u00a0comparison of 99mTc-mebrofenin scintigraphy with indocyanine green clearance test. Liver Int 24(2):117\u2013123","journal-title":"Liver Int"},{"issue":"1","key":"718_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/SLA.0b013e3181ad85b5","volume":"250","author":"M Stockmann","year":"2009","unstructured":"Stockmann M, Lock JF, Riecke B, Heyne K, Martus P, Fricke M et\u00a0al (2009) Prediction of postoperative outcome after hepatectomy with a\u00a0new bedside test for maximal liver function capacity. Ann Surg 250(1):119\u2013125","journal-title":"Ann Surg"},{"issue":"2","key":"718_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1477-2574.2009.00151.x","volume":"12","author":"M Stockmann","year":"2010","unstructured":"Stockmann M, Lock JF, Malinowski M, Niehues SM, Seehofer D, Neuhaus P (2010) The LiMAx test: a\u00a0new liver function test for predicting postoperative outcome in liver surgery. HPB (Oxford) 12(2):139\u2013146","journal-title":"HPB (Oxford)"},{"issue":"1","key":"718_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1245\/s10434-008-0180-z","volume":"16","author":"H Nathan","year":"2009","unstructured":"Nathan H, Aloia TA, Vauthey JN, Abdalla EK, Zhu AX, Schulick RD et\u00a0al (2009) A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 16(1):14\u201322","journal-title":"Ann Surg Oncol"},{"issue":"23","key":"718_CR19","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1200\/JCO.2011.35.6519","volume":"29","author":"MC Jong de","year":"2011","unstructured":"de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H et al (2011) Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J\u00a0Clin Oncol 29(23):3140\u20133145","journal-title":"J Clin Oncol"},{"issue":"11","key":"718_CR20","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1245\/s10434-015-4501-8","volume":"22","author":"JT Miura","year":"2015","unstructured":"Miura JT, Johnston FM, Tsai S, George B, Thomas J, Eastwood D et\u00a0al (2015) Chemotherapy for surgically resected intrahepatic cholangiocarcinoma. Ann Surg Oncol 22(11):3716\u20133723","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"718_CR21","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T et\u00a0al (2014) Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J\u00a0Hepatol 60(6):1268\u20131289","journal-title":"J Hepatol"},{"issue":"1","key":"718_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/SLA.0b013e3181e462e6","volume":"252","author":"G Ercolani","year":"2010","unstructured":"Ercolani G, Vetrone G, Grazi GL, Aramaki O, Cescon M, Ravaioli M et\u00a0al (2010) Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. Ann Surg 252(1):107\u2013114","journal-title":"Ann Surg"},{"issue":"1","key":"718_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1245\/s10434-015-4642-9","volume":"23","author":"G Spolverato","year":"2016","unstructured":"Spolverato G, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L et al (2016) Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection. Ann Surg Oncol 23(1):235\u2013243","journal-title":"Ann Surg Oncol"},{"issue":"15_suppl","key":"718_CR24","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1200\/JCO.2017.35.15_suppl.4006","volume":"35","author":"JN Pimrose","year":"2017","unstructured":"Pimrose JN (2017) Adjuvant capecitabine for biliary tract cancer: the BILCAP randomized study. J\u00a0Clin Oncol 35(15_suppl):4006","journal-title":"J Clin Oncol"},{"key":"718_CR25","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1186\/s12885-015-1498-0","volume":"15","author":"A Stein","year":"2015","unstructured":"Stein A, Arnold D, Bridgewater J, Goldstein D, Jensen LH, Klumpen HJ et al (2015) Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial)\u2014a\u00a0randomized, multidisciplinary, multinational phase III trial. BMC Cancer 15:564","journal-title":"BMC Cancer"},{"issue":"3","key":"718_CR26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/jso.24524","volume":"115","author":"S Buettner","year":"2017","unstructured":"Buettner S, Koerkamp BG, Ejaz A, Buisman FE, Kim Y, Margonis GA et al (2017) The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients\u2014a multi-institutional analysis. J\u00a0Surg Oncol 115(3):312\u2013318","journal-title":"J Surg Oncol"},{"issue":"5","key":"718_CR27","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jvir.2012.01.081","volume":"23","author":"Y Fu","year":"2012","unstructured":"Fu Y, Yang W, Wu W, Yan K, Xing BC, Chen MH (2012) Radiofrequency ablation in the management of unresectable intrahepatic cholangiocarcinoma. J\u00a0Vasc Interv Radiol 23(5):642\u2013649","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"718_CR28","doi-asserted-by":"publisher","first-page":"W205","DOI":"10.2214\/AJR.10.4937","volume":"196","author":"JH Kim","year":"2011","unstructured":"Kim JH, Won HJ, Shin YM, Kim KA, Kim PN (2011) Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma. AJR Am J Roentgenol 196(2):W205\u2013W209","journal-title":"AJR Am. J. Roentgenol."},{"issue":"8","key":"718_CR29","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.jvir.2013.03.019","volume":"24","author":"CE Ray Jr.","year":"2013","unstructured":"Ray CE Jr., Edwards A, Smith MT, Leong S, Kondo K, Gipson M et al (2013) Metaanalysis of survival, complications, and imaging response following chemotherapy-based transarterial therapy in patients with unresectable intrahepatic cholangiocarcinoma. J\u00a0Vasc Interv Radiol 24(8):1218\u20131226","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"718_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5009\/gnl.2010.4.1.103","volume":"4","author":"JS Park","year":"2010","unstructured":"Park JS, Lee DH, Jeong S, Kim WC, Lee JI, Lee SY et\u00a0al (2010) Concurrent chemoradiation in a\u00a0patient with unresectable cholangiocarcinoma. Gut Liver 4(1):103\u2013105","journal-title":"Gut Liver"},{"issue":"2","key":"718_CR31","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1245\/s10434-009-0777-x","volume":"17","author":"A Saxena","year":"2010","unstructured":"Saxena A, Bester L, Chua TC, Chu FC, Morris DL (2010) Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a\u00a0preliminary assessment of this novel treatment option. Ann Surg Oncol 17(2):484\u2013491","journal-title":"Ann Surg Oncol"},{"issue":"14","key":"718_CR32","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A et\u00a0al (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N\u00a0Engl J Med 362(14):1273\u20131281","journal-title":"N Engl J Med"},{"issue":"3","key":"718_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4143\/crt.2014.308","volume":"47","author":"JO Park","year":"2015","unstructured":"Park JO, Oh DY, Hsu C, Chen JS, Chen LT, Orlando M et\u00a0al (2015) Gemcitabine plus cisplatin for advanced biliary tract cancer: a systematic review. Cancer Res Treat 47(3):343\u2013361","journal-title":"Cancer Res Treat"},{"issue":"6","key":"718_CR34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1159\/000453084","volume":"32","author":"RR Plentz","year":"2016","unstructured":"Plentz RR, Malek NP (2016) Systemic therapy of cholangiocarcinoma. Visc Med 32(6):427\u2013430","journal-title":"Visc Med"},{"issue":"7","key":"718_CR35","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.3748\/wjg.v21.i7.2096","volume":"21","author":"JF Guion-Dusserre","year":"2015","unstructured":"Guion-Dusserre JF, Lorgis V, Vincent J, Bengrine L, Ghiringhelli F (2015) FOLFIRI plus bevacizumab as a\u00a0second-line therapy for metastatic intrahepatic cholangiocarcinoma. World J Gastroenterol 21(7):2096\u20132101","journal-title":"World J Gastroenterol"},{"issue":"3","key":"718_CR36","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1200\/JCO.2017.75.5009","volume":"36","author":"M Javle","year":"2018","unstructured":"Javle M, Lowery M, Shroff RT, Weiss KH, Springfeld C, Borad MJ et al (2018) Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma. J\u00a0Clin Oncol 36(3):276\u2013282","journal-title":"J Clin Oncol"},{"issue":"5","key":"718_CR37","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1097\/SLA.0000000000000494","volume":"259","author":"G Sapisochin","year":"2014","unstructured":"Sapisochin G, de Lope CR, Gastaca M, de Urbina JO, Lopez-Andujar R, Palacios F et al (2014) Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a\u00a0Spanish matched cohort multicenter study. Ann Surg 259(5):944\u2013952","journal-title":"Ann Surg"},{"issue":"6","key":"718_CR38","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/archsurg.2011.116","volume":"146","author":"JC Hong","year":"2011","unstructured":"Hong JC, Jones CM, Duffy JP, Petrowsky H, Farmer DG, French S et al (2011) Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a\u00a024-year experience in a\u00a0single center. Arch Surg 146(6):683\u2013689","journal-title":"Arch Surg"},{"issue":"3","key":"718_CR39","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/ajt.12591","volume":"14","author":"G Sapisochin","year":"2014","unstructured":"Sapisochin G, Rodriguez de Lope C, Gastaca M, Ortiz de Urbina J, Suarez MA, Santoyo J et\u00a0al (2014) \u201cVery early\u201d intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients? Am J Transplant 14(3):660\u2013667","journal-title":"Am J Transplant"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00104-018-0718-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-018-0718-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-018-0718-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T23:30:45Z","timestamp":1567553445000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00104-018-0718-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["718"],"URL":"https:\/\/doi.org\/10.1007\/s00104-018-0718-y","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]},"assertion":[{"value":"4 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"G.\u00a0Lurje, J.\u00a0Bednarsch, C.\u00a0Roderburg, C.\u00a0Trautwein und U.P.\u00a0Neumann geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}